Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on July 26, 2017, to report its second-quarter financial results for the period ended June 30, 2017. The primary purpose of this filing was to furnish a press release detailing these results, which is included as Exhibit 99.1. Investors should note that this information is furnished and not deemed "filed" for certain regulatory purposes, meaning it may not be automatically incorporated into future SEC filings unless specifically referenced. The press release itself contains the key financial performance metrics for the quarter. While the 8-K itself does not provide the detailed figures, it serves as the official notification that these results have been made public. Investors looking for specific financial performance data, such as revenue, earnings per share, and any forward-looking guidance or commentary provided by management, will need to refer to the furnished press release (Exhibit 99.1) for those details.
Key Highlights
- 1Elevance Health (then Anthem, Inc.) announced its Q2 2017 financial results via an 8-K filing on July 26, 2017.
- 2The filing primarily serves to furnish a press release (Exhibit 99.1) containing the detailed Q2 2017 financial and operational results.
- 3The press release date was July 26, 2017, covering the quarter ended June 30, 2017.
- 4Information furnished in this 8-K is not considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
- 5Investors should consult Exhibit 99.1 for the specific financial performance data and management commentary.
- 6The company was not an emerging growth company at the time of this filing.